14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $14.73 $16.67 Wednesday, 24th Apr 2024 CPRX stock ended at $15.12. This is 2.65% more than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 2.99% from a day low at $14.74 to a day high of $15.18.
90 days $13.12 $17.50
52 weeks $11.09 $17.77

Historical Catalyst Pharmaceuticals prices

Date Open High Low Close Volume
Apr 24, 2024 $14.80 $15.18 $14.74 $15.12 941 410
Apr 23, 2024 $15.20 $15.22 $14.73 $14.73 989 873
Apr 22, 2024 $15.28 $15.35 $14.94 $15.10 987 416
Apr 19, 2024 $15.34 $15.80 $15.03 $15.13 5 294 551
Apr 18, 2024 $16.03 $16.25 $15.33 $15.34 1 361 380
Apr 17, 2024 $15.70 $16.06 $15.62 $16.00 1 365 635
Apr 16, 2024 $15.22 $15.69 $15.16 $15.54 898 561
Apr 15, 2024 $15.49 $15.87 $15.36 $15.39 1 263 235
Apr 12, 2024 $15.86 $15.86 $15.08 $15.22 817 840
Apr 11, 2024 $15.94 $16.06 $15.52 $15.81 681 707
Apr 10, 2024 $15.41 $15.97 $15.25 $15.88 1 017 717
Apr 09, 2024 $15.53 $15.82 $15.42 $15.79 821 674
Apr 08, 2024 $15.29 $15.91 $15.17 $15.51 908 023
Apr 05, 2024 $15.02 $15.33 $14.97 $15.17 823 526
Apr 04, 2024 $15.54 $15.62 $15.07 $15.12 757 835
Apr 03, 2024 $15.21 $15.50 $15.05 $15.49 992 437
Apr 02, 2024 $15.45 $15.46 $15.14 $15.26 1 095 095
Apr 01, 2024 $15.79 $15.86 $15.36 $15.74 1 004 375
Mar 28, 2024 $16.29 $16.50 $15.78 $15.94 1 124 342
Mar 27, 2024 $15.90 $16.67 $15.89 $16.27 1 317 449
Mar 26, 2024 $16.00 $16.14 $15.73 $15.75 796 442
Mar 25, 2024 $15.77 $16.03 $15.67 $15.86 1 051 244
Mar 22, 2024 $16.60 $16.60 $15.71 $15.73 894 483
Mar 21, 2024 $16.99 $17.43 $16.61 $16.62 1 579 379
Mar 20, 2024 $16.30 $16.93 $16.26 $16.91 893 767
Click to get the best stock tips daily for free!

About Catalyst Pharmaceuticals

Catalyst Pharmaceuticals Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develop... CPRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT